USPTO serial 76294206
CELLZOME
Reviewed by CopyMark Law Group
Reg. 2749380Status 710
- Filing date
- Status date
- Registration date
- Aug 12, 2003
- Examiner
- PIGNATELLO, ELIZABETH
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CELLZOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
HEIDELBERG, DE
69117 Heidelberg, DE
HEIDELBERG, DE
HEIDELBERG, DE
HEIDELBERG, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Terence A. Dixon
Terence A. Dixon GLAXOSMITHKLINEOne Franklin Plaza, 200 N. 16th StreetFP2030Philadelphia, PA 19102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical and biological reagents for industrial and scientific research; chemical and biological reagents for scientific laboratory analysis ] | SECTION 8 - CANCELLED | — |
| 005 | [ Pharmaceutical preparations and formulations, diagnostic preparations and medicated health preparations for use in the diagnosis and treatment of human diseases or disorders, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal infections, dermatological, inherited developmental disorders, psychological mental, psychiatric, metabolic and central nervous system diseases or disorders including neurodegenerative disorders; veterinary preparations and formulations, namely, vaccines for birds and mammals, namely, livestock, cats, dogs and rodents; insecticides, fungicides and herbicides for commercial, agricultural and domestic use; diagnostic reagents for clinical or medical laboratory use ] | SECTION 8 - CANCELLED | — |
| 042 | Product research and development services rendered to others in the biological medical field; medical, research and laboratory diagnostic services in the biological-medical field; computer programming for others in the biological-medical field, [ computer services, namely, providing databases and information in the fields of biological science and medicine, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the fields of biological science and medicine; ] licensing of intellectual property | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELLZOME GMBH
- Other trademarks owned by CELLZOME GMBH
- Other trademarks owned by CELLZOME AG
- Other trademarks owned by CELLZOME AG
- Other trademarks owned by CELLZOME AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CELLZOME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 14, 2014 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Nov 21, 2012 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 6, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 6, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 14, 2009 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 11, 2009 | PLGL | ASSIGNED TO PARALEGAL | — |
| Aug 6, 2009 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Aug 6, 2009 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 2, 2008 | CFIT | CASE FILE IN TICRS | — |
| Aug 12, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 20, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 30, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 3, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2002 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Dec 9, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2002 | PAPER RECEIVED | — | |
| Jun 26, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2002 | PAPER RECEIVED | — | |
| Sep 14, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2001 | DOCK | ASSIGNED TO EXAMINER | — |